Rainbow Children's Medicare Ltd
NSE:RAINBOW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
|
CN |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (39), the stock would be worth ₹1 399.42 (10% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 35.6 | ₹1 276.2 |
0%
|
| 3-Year Average | 39 | ₹1 399.42 |
+10%
|
| 5-Year Average | 37.4 | ₹1 339.5 |
+5%
|
| Industry Average | 42.5 | ₹1 524.67 |
+19%
|
| Country Average | 23.3 | ₹834.03 |
-35%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
₹125.4B
|
/ |
Jan 2026
₹3.7B
|
= |
|
|
₹125.4B
|
/ |
Mar 2026
₹4B
|
= |
|
|
₹125.4B
|
/ |
Mar 2027
₹4.9B
|
= |
|
|
₹125.4B
|
/ |
Mar 2028
₹5.7B
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
R
|
Rainbow Children's Medicare Ltd
NSE:RAINBOW
|
129.6B INR | 35.6 | 50.3 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
107.5B USD | 12.2 | 15.9 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 40 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
24B ZAR | 9.5 | 14.3 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.2B MYR | 22.6 | 36.8 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
18B ZAR | -53.4 | 4.7 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
87B BRL | 9.4 | 18.6 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
16.1B USD | 7.1 | 11.8 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
90.4B CNY | 20 | 28.1 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 42.9 | 61.3 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
11.1B USD | 24.6 | 31.7 |
Market Distribution
| Min | 0.4 |
| 30th Percentile | 15.7 |
| Median | 23.3 |
| 70th Percentile | 34.7 |
| Max | 48 145.1 |
Other Multiples
Rainbow Children's Medicare Ltd
Glance View
Rainbow Children's Medicare Ltd. embarked on its journey with a clear mission: to cater to the specialized healthcare needs of children. Nestled in the bustling corridors of India’s urban landscape, it emerged as a beacon of pediatric care, blending medical expertise with compassionate service. The company focuses on providing multi-specialty healthcare strictly for children, believing that specialized attention is key to superior medical outcomes. Over the years, Rainbow Children’s has cultivated a robust network of hospitals and clinics across multiple cities, each facility echoing the company’s commitment to innovative, child-focused treatment methodologies. Strategically, Rainbow Children’s Medicare Ltd. thrives by offering a broad spectrum of pediatric services under one roof, which ensures a steady flow of clientele seeking diverse medical needs. This includes everything from routine check-ups and immunizations to complex procedures and intensive care. By establishing itself as a trust-worthy center for both routine and critical pediatric care, the company successfully draws a consistent and growing demand for its services. Financially, Rainbow Children's strengthens its revenue streams by strategically positioning hospitals in growing urban areas, tapping into insurance partnerships, and continually enhancing its offerings with advanced medical technologies and specialized care units. This strategic approach not only boosts operational efficiency but also ensures long-term sustainable growth as an essential player in the healthcare sector.